PRESS RELEASE published on 05/16/2023 at 12:45, 3 years 5 months ago NanoViricides Has Filed its Quarterly Report - Clinical Trials of Broad-Spectrum COVID Drug About to Begin
PRESS RELEASE published on 04/25/2023 at 12:45, 3 years 5 months ago NanoViricides is Expanding its Broad-Spectrum Antiviral Program to Explore Further Antiviral Applications of its COVID Clinical Drug Ingredient
PRESS RELEASE published on 04/17/2023 at 12:45, 3 years 6 months ago NanoViricides Has Shipped Drug Products for Impending Clinical Trials of NV-CoV-2, Its COVID Drug Candidate
PRESS RELEASE published on 04/04/2023 at 13:45, 3 years 6 months ago NanoViricides Signs a License Agreement That Includes Clinical Evaluation of Its COVID-19 Drug Candidates
PRESS RELEASE published on 02/15/2023 at 12:30, 3 years 8 months ago NanoViricides Has Filed its Quarterly Report - Company has Begun Production of Coronavirus Drug for Clinical Trials
PRESS RELEASE published on 01/04/2023 at 12:35, 3 years 9 months ago NanoViricides, Inc. to Present at the Biotech Showcase(TM) 2023 Conference in San Fransisco on January 9th at 10:30am PT
Published on 10/19/2026 at 23:20, 1 hour 14 minutes ago CoTec Holdings Corp. Announces Investor Awareness Agreements
Published on 10/19/2026 at 23:00, 1 hour 34 minutes ago Eskay Mining Corp. Announces Results of Annual Meeting
Published on 10/19/2026 at 22:50, 1 hour 44 minutes ago Bluesky Digital Announces Termination of ChessGold Inc. Transaction and Management and Director Changes
Published on 10/19/2026 at 22:01, 2 hours 33 minutes ago Unusual Machines Completes Acquisition of Upgrade Energy, Expanding U.S. Drone Battery Manufacturing
Published on 10/19/2026 at 22:16, 2 hours 18 minutes ago EQS-Adhoc: Pentixapharm Holding AG: 2026 Earnings Guidance Raised; First-Patient Enrollment in PANDA Phase 3 Study Now Expected in the First Quarter of 2027
Published on 10/19/2026 at 21:22, 3 hours 12 minutes ago EQS-Adhoc: Cantourage Group SE: Supervisory Board Resolves to Transition to IFRS Following First-Time Requirement to Prepare Consolidated Financial Statements
Published on 10/19/2026 at 19:00, 5 hours 34 minutes ago PATRIMOINE ET COMMERCE : Déclaration des transactions sur actions propres (Hors contrat de liquidité) réalisées du 12/10/2026 au 16/10/2026
Published on 10/19/2026 at 18:05, 6 hours 29 minutes ago Cognizant and Google Cloud Expand Alliance to Accelerate Agentic Enterprise Transformation
Published on 10/19/2026 at 17:45, 6 hours 49 minutes ago VALBIOTIS SA: Valbiotis receives double “Best Pharma Product 2027” award for its ValbiotisPRO® Cholestérol and ValbiotisPRO® Santé Métabolique solutions
Published on 10/19/2026 at 19:00, 5 hours 34 minutes ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 : Compte rendu et résultat des votes - Évolution de la gouvernance
Published on 10/19/2026 at 18:40, 5 hours 54 minutes ago Reporting on share buyback transactions carried out between October 12 and October 13, 2026
Published on 10/19/2026 at 18:40, 5 hours 54 minutes ago Déclaration de rachats d'actions effectués par la Compagnie de Saint-Gobain les 12 et 13 octobre 2026
Published on 10/19/2026 at 18:00, 6 hours 34 minutes ago WHO Grants Emergency Use Listing for BIOFIRE® Global Fever Special Pathogens Panel, Expanding Access to Differential Diagnostics for the Ebola Response
Published on 10/19/2026 at 18:00, 6 hours 34 minutes ago L’OMS accorde une autorisation d’utilisation d’urgence au test BIOFIRE® Global Fever Special Pathogens, élargissant l’accès au diagnostic différentiel face à l’épidémie d’Ebola
